Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:00 pm Purchase | 2026-03-31 | 13G | LIPOCINE INC INC LPCN | Ikarian Capital, LLC | 508,556 6.300% | 508,556 (New Position) | Filing History |
| 2026-05-15 4:59 pm Unchanged | 2026-03-31 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Ikarian Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-05-15 4:56 pm Purchase | 2026-03-31 | 13G | PELTHOS THERAPEUTICS INC PTHS | Ikarian Capital, LLC | 256,598 7.700% | 840 (+0.33%) | Filing History |
| 2026-05-07 5:13 pm Unchanged | 2026-04-30 | 13G | SPRUCE BIOSCIENCES INC SPRB | Ikarian Capital, LLC | 121,356 4.800% | 0 (Unchanged) | Filing History |
| 2026-04-17 4:57 pm Purchase | 2025-12-31 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Ikarian Capital, LLC | 45,830 5.700% | 45,830 (New Position) | Filing History |
| 2026-04-07 9:34 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Ikarian Capital, LLC | 1,145,100 6.700% | 177,500 (+18.34%) | Filing History |
| 2026-03-06 4:43 pm Purchase | 2026-02-28 | 13G | GALECTO INC GLTO | Ikarian Capital, LLC | 335,710 0.600% | 50,000 (+17.50%) | Filing History |
| 2026-02-17 5:47 pm Purchase | 2025-12-31 | 13G | KAZIA THERAPEUTICS LTD SPONSOR KZIA | Ikarian Capital, LLC | 580,754 5.100% | 580,754 (New Position) | Filing History |
| 2026-02-17 5:28 pm Purchase | 2025-12-31 | 13G | NEXTCURE INC NXTC | Ikarian Capital, LLC | 363,035 9.990% | 363,035 (New Position) | Filing History |
| 2026-02-17 5:23 pm Purchase | 2025-12-31 | 13G | GLUCO TRACK INC GCTK | Ikarian Capital, LLC | 45,830 4.500% | 45,830 (New Position) | Filing History |
| 2026-02-17 5:22 pm Purchase | 2025-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Ikarian Capital, LLC | 4,933,086 8.800% | 4,933,086 (New Position) | Filing History |
| 2026-02-17 5:16 pm Purchase | 2025-12-31 | 13G | ALPHA COGNITION INC NE ACOG | Ikarian Capital, LLC | 1,056,259 4.900% | 88,392 (+9.13%) | Filing History |
| 2026-02-17 5:14 pm Purchase | 2025-12-31 | 13G | PELTHOS THERAPEUTICS INC PTHS | Ikarian Capital, LLC | 255,758 8.400% | 69,350 (+37.20%) | Filing History |
| 2026-02-17 5:11 pm Purchase | 2025-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ikarian Capital, LLC | 812,524 9.990% | 223,022 (+37.83%) | Filing History |
| 2026-02-17 5:09 pm Sale | 2025-12-31 | 13G | AVENUE THERAPEUTICS INC PA ATXI | Ikarian Capital, LLC | 130,820 4.100% | -9,180 (-6.56%) | Filing History |
| 2026-02-06 5:28 pm Unchanged | 2026-01-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Ikarian Capital, LLC | 211,538 12.600% | 0 (Unchanged) | Filing History |
| 2025-12-15 9:53 pm Purchase | 2025-11-30 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Ikarian Capital, LLC | 211,538 25.200% | 211,538 (New Position) | Filing History |
| 2025-12-05 4:51 pm Unchanged | 2025-11-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Ikarian Capital, LLC | 967,600 15.500% | 0 (Unchanged) | Filing History |
| 2025-12-05 4:50 pm Purchase | 2025-11-30 | 13G | GALECTO INC GLTO | Ikarian Capital, LLC | 285,710 21.500% | 285,710 (New Position) | Filing History |
| 2025-11-14 6:33 pm Purchase | 2025-09-30 | 13G | PELTHOS THERAPEUTICS INC PTHS | Ikarian Capital, LLC | 186,408 6.100% | 142,323 (+322.84%) | Filing History |